Opiates Test Evidence
Has Caused a False Positive
Doxylamine
Source Hausmann et al., J Clin Chem Clin Biochem 1983
What It Found
- An opiate screen was positive during doxylamine poisoning.
- An alternative opiate radioimmunoassay was negative.
Keep in Mind
- This concerns intoxication on an older reagent.
- The same report separately documented methadone-screen interference.
Test Studied
- Syva-Merck EMIT-ST opiates
Source Smith et al., J Anal Toxicol 2000
What It Found
- Adding 1 mg/mL of Doxylamine to urine already containing 300 ng/mL morphine significantly increased the apparent morphine signal on EMIT, CEDIA and Abbott AxSYM.
Keep in Mind
- This specific experiment demonstrates signal enhancement in morphine-positive urine.
- It did not test whether this drug alone can make morphine-free urine positive.
Test Studied
- EMIT, CEDIA and Abbott AxSYM opiate urine assays, morphine-spiked specimens
Gatifloxacin
Source Baden et al., JAMA 2001
What It Found
- Added gatifloxacin reacted on EMIT II.
Test Studied
- Historical EMIT II opiates
Source Straley et al., Pharmacotherapy 2006
What It Found
- A patient receiving systemic gatifloxacin also had two positive screens with negative follow-up testing by another method.
Test Studied
- A clinical urine case
Both sources Baden et al., JAMA 2001 Straley et al., Pharmacotherapy 2006
Keep in Mind
- This evidence concerns systemic gatifloxacin exposure.
- It does not establish a similar effect with ophthalmic products.
Levofloxacin
Source Baden et al., JAMA 2001
What It Found
- Oral levofloxacin yielded presumptive opiate positives in controlled volunteer testing.
Source Colby et al., Clin Biochem 2019
What It Found
- A modern spiking study reproduced the effect with Abbott MULTIGENT at concentrations achievable during treatment.
Keep in Mind
- The modern study found no levofloxacin cross-reaction with its dedicated oxycodone or methadone screens.
Test Studied
- Abbott MULTIGENT opiates
3 sources Baden et al., JAMA 2001 Colby et al., Clin Biochem 2019 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
Keep in Mind
- Individual fluoroquinolones and different assays behave differently.
2 sources Baden et al., JAMA 2001 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
Test Studied
- Older CEDIA, EMIT II, Roche OnLine and AxSYM
Also cited: Shafiq and Mutgi, CMAJ 2010
Ofloxacin
Source Meatherall and Dai, Ther Drug Monit 1997
What It Found
- Several patients taking therapeutic oral ofloxacin and two volunteers after a single dose had false positives on EMIT II.
- Spiked urine also reacted.
Test Studied
- EMIT II opiates
3 sources Meatherall and Dai, Ther Drug Monit 1997 Baden et al., JAMA 2001 Backmund et al., Addict Biol 2000
Keep in Mind
- Findings from systemic treatment do not demonstrate a risk with ofloxacin ear or eye drops.
3 sources Baden et al., JAMA 2001 Backmund et al., Addict Biol 2000 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
Test Studied
- Other morphine-calibrated assays
Perazine
Source Schmolke et al., Clin Chem 1996
What It Found
- A 1996 case described positive opiate and amphetamine immunoassays during perazine intoxication.
Keep in Mind
- A single intoxication report with no abstract in the indexed record does not establish a response at routine doses.
Tests Studied
- Urine opiate immunoassay
- Platform unverified
Enoxacin
Source Baden et al., JAMA 2001
What It Found
- Added enoxacin reached the opiate cutoff in two of five assay systems.
- The required concentrations exceeded the expected peak with standard dosing in that paper.
Keep in Mind
- A laboratory effect at high concentrations is weak support for an explanation after an ordinary prescription.
Test Studied
- Historical CEDIA and EMIT II opiates
Hordenine
Source Singh et al., Forensic Sci Int 1992
What It Found
- Hordenine reacted most strongly with the morphine ELISA among the opioid tests compared.
Keep in Mind
- The source discusses possible exposure through barley or beer.
- It does not show a positive test following beer consumption in a person.
Test Studied
- Historical urine morphine ELISA, compared with other opioid ELISA and RIA kits
Lomefloxacin
Source Baden et al., JAMA 2001
What It Found
- Of five opiate methods studied, only Roche OnLine became positive with high concentrations of added lomefloxacin.
Keep in Mind
- The positive range exceeded the authors' predicted peak urinary concentration.
- Clinical cases were not presented for this ingredient.
Test Studied
- Historical Roche OnLine opiates
Pefloxacin
Source Baden et al., JAMA 2001
What It Found
- Pefloxacin crossed the positive threshold on three assays in spiked urine.
- Of these, the authors considered the CEDIA reaction the most relevant at predicted urine concentrations.
Keep in Mind
- The volunteers studied in this paper received levofloxacin or ofloxacin.
- The pefloxacin result was analytical.
Test Studied
- CEDIA, EMIT II and Roche OnLine opiates (historical comparison)
Ranitidine
Source Ayala-Lopez et al., J Anal Toxicol 2022
What It Found
- The opiates strip became positive with ranitidine added at 1,600 micrograms/mL.
Keep in Mind
- An incidental high-concentration result on one point-of-care cup.
- Check the ingredient on the product because the Zantac brand has also been used for famotidine.
Test Studied
- Alere Integrated E-Z Split Key Cup II, opiates strip
Depends on the Brand of Test
Ciprofloxacin
Source Baden et al., JAMA 2001
What It Found
- Only a high-concentration Roche laboratory challenge turned positive.
Source Meatherall and Dai, Ther Drug Monit 1997
What It Found
- Urine from three patients taking ciprofloxacin was negative on EMIT II.
Source Colby et al., Clin Biochem 2019
What It Found
- A 2019 panel showed no ciprofloxacin reactivity.
Test Studied
- The later Abbott panel
All 3 sources Baden et al., JAMA 2001 Meatherall and Dai, Ther Drug Monit 1997 Colby et al., Clin Biochem 2019
Keep in Mind
- A blanket warning for every fluoroquinolone would overstate the evidence for ciprofloxacin.
2 sources Baden et al., JAMA 2001 Meatherall and Dai, Ther Drug Monit 1997
Test Studied
- Historical Roche OnLine versus EMIT II
Dextromethorphan
2 sources Marshall et al., Clin Chim Acta 2025 Finn et al., Clin Chim Acta 2015
What It Found
- A high-dose case and spiking experiments support interference on some reagents.
Test Studied
- Selected rapid opiate immunoassays after high-dose exposure
Source Storrow et al., Acad Emerg Med 1995
What It Found
- In a crossover study of 20 adults, urine EMIT screens were negative six hours after 20 or 40 mg of dextromethorphan.
Test Studied
- EMIT in a controlled study
Source Vanzetti et al., Clin Chem 1983
What It Found
- Very high concentrations of dextromethorphan reacted weakly with this experimental morphine test.
Keep in Mind
- The mean relative molar reactivity was about 0.3% in this antibody series.
Test Studied
- Historical morphine hemagglutination-inhibition assay
Source Smith et al., J Anal Toxicol 2000
What It Found
- Adding 1 mg/mL of Dextromethorphan to urine already containing 300 ng/mL morphine significantly increased the apparent morphine signal on Roche OnLine, EMIT, CEDIA and Abbott AxSYM.
Keep in Mind
- This specific experiment demonstrates signal enhancement in morphine-positive urine.
- It did not test whether this drug alone can make morphine-free urine positive.
Test Studied
- Roche OnLine, EMIT, CEDIA and Abbott AxSYM opiate urine assays, morphine-spiked specimens
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Dextromethorphan at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
3 sources Marshall et al., Clin Chim Acta 2025 Finn et al., Clin Chim Acta 2015 Storrow et al., Acad Emerg Med 1995
Keep in Mind
- Dose, reagent and timing matter.
- These studies do not establish a prediction for a particular user's result.
Diphenhydramine
Source Temple and Thompson, Clin Toxicol (Phila) 2022
What It Found
- A Clinical Toxicology report identified an opiate-screen false positive associated with diphenhydramine.
Keep in Mind
- The indexed letter gives no abstract.
- Dose, device and frequency cannot be assigned from that record.
Tests Studied
- Rapid urine opiate immunoassay
- Exact device unverified
Source Smith et al., J Anal Toxicol 2000
What It Found
- Adding 1 mg/mL of Diphenhydramine to urine already containing 300 ng/mL morphine significantly increased the apparent morphine signal on EMIT, CEDIA and Abbott AxSYM.
Keep in Mind
- This specific experiment demonstrates signal enhancement in morphine-positive urine.
- It did not test whether this drug alone can make morphine-free urine positive.
Test Studied
- EMIT, CEDIA and Abbott AxSYM opiate urine assays, morphine-spiked specimens
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Diphenhydramine at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Naloxone
Source Straseski et al., Clin Chem 2010
What It Found
- A child's urine contained enough naloxone to reproduce the CEDIA signal in spiking experiments.
Keep in Mind
- The positive case involved high urine naloxone.
- Administration for suspected overdose also makes review of actual opioid exposure essential.
Test Studied
- CEDIA opiates (300 ng/mL cutoff)
Source Storrow et al., Ann Emerg Med 1994
What It Found
- A separate controlled EMIT study found no positives in 14 adults given single IV doses of 2 or 4 mg.
Test Studied
- EMIT opiates in volunteers
Source Vanzetti et al., Clin Chem 1983
What It Found
- The historical hemagglutination antibody series had less than 0.1% relative reactivity to Naloxone.
Keep in Mind
- Reactivity depends on the antibody.
- This experiment did not predict every morphine screening method.
Test Studied
- Historical experimental morphine hemagglutination-inhibition assay
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 0.1% relative response to Naloxone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS opiates urine application on cobas c 501, Table 4
Norfloxacin
Source Baden et al., JAMA 2001
What It Found
- An older Roche assay became positive at high spiked concentrations.
Keep in Mind
- The Roche reaction occurred above typical urinary concentrations cited by the investigators.
Test Studied
- Historical Roche OnLine
Source Meatherall and Dai, Ther Drug Monit 1997
What It Found
- EMIT II was negative in three patients on norfloxacin and in the corresponding spiking experiment.
Test Studied
- EMIT II
Oxycodone
Source Smith et al., J Anal Toxicol 1995
What It Found
- After a controlled dose of oxycodone, two general opiates tests (TDx and EMIT at a 300 ng/mL cutoff) detected the prescribed opioid in urine.
- Abuscreen and Coat-A-Count missed oxycodone.
Keep in Mind
- An opiates-class result alone cannot identify the individual opioid.
- The findings depend on the product, cutoff and urine concentration.
Tests Studied
- TDx Opiates, EMIT d.a.u
- Opiate, Abuscreen radioimmunoassay and Coat-A-Count morphine, with urine GC-MS
Source Moody et al., J Anal Toxicol 2006
What It Found
- The Instant-View device showed low sensitivity for oxycodone-positive urine in this comparison.
Keep in Mind
- This is limited detection of a related opioid on a class test.
- Oxycodone-specific assays use different antibodies.
Test Studied
- Instant-View Test Card and OnTrak TesTcup Pro 5 morphine-class screens, compared against GC-MS
Source Vanzetti et al., Clin Chem 1983
What It Found
- The historical hemagglutination antibody series had less than 0.1% relative reactivity to Oxycodone.
Keep in Mind
- Reactivity depends on the antibody.
- This experiment did not predict every morphine screening method.
Test Studied
- Historical experimental morphine hemagglutination-inhibition assay
Source Eldefrawi et al., Appl Biochem Biotechnol 2000
What It Found
- Codeine, oxycodone and morphine-6-glucuronide showed more than 50% relative reaction at 1 µg/mL in the experimental system.
Keep in Mind
- The clinical comparison evaluated the overall method, rather than individual drug-only post-dose urines.
Test Studied
- Custom competitive morphine-antibody fluoroimmunoassay
Source Smith et al., J Anal Toxicol 2000
What It Found
- The study compared Oxycodone in fortified urine against morphine.
- At 300 ng/mL, reactivity varied by reagent and generally favored codeine or hydrocodone over oxycodone or oxymorphone.
Keep in Mind
- Relative reactivity is concentration-dependent.
- A measurable signal does not always cross the cutoff.
Test Studied
- Six Roche OnLine, Syva EMIT, CEDIA and AxSYM opiate immunoassay applications
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 0.37% relative response to Oxycodone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS opiates urine application on cobas c 501, Table 4
Oxymorphone
Source Smith et al., J Anal Toxicol 1995
What It Found
- After a single dose of oxymorphone, none of four morphine-directed opiates screens detected it in the collected urine samples.
- GC-MS measured the drug.
Keep in Mind
- An oxycodone/oxymorphone-specific test can detect oxymorphone.
- A negative broad opiates screen cannot exclude exposure.
Tests Studied
- TDx Opiates, EMIT d.a.u
- Opiate, Abuscreen radioimmunoassay and Coat-A-Count morphine, with urine GC-MS
Source Smith et al., J Anal Toxicol 2000
What It Found
- The study compared Oxymorphone in fortified urine against morphine.
- At 300 ng/mL, reactivity varied by reagent and generally favored codeine or hydrocodone over oxycodone or oxymorphone.
Keep in Mind
- Relative reactivity is concentration-dependent.
- A measurable signal does not always cross the cutoff.
Test Studied
- Six Roche OnLine, Syva EMIT, CEDIA and AxSYM opiate immunoassay applications
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 0.32% relative response to Oxymorphone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS opiates urine application on cobas c 501, Table 4
Rifampin
3 sources Lam et al., Pract Lab Med 2023 de Paula et al., Clin Chem Lab Med 1998 Herrera Trevilla et al., J Anal Toxicol 1995
What It Found
- Rifampin produced unconfirmed opiates screens with Roche KIMS.
Test Studied
- Roche KIMS assays
Source Lam et al., Pract Lab Med 2023
What It Found
- Including a child whose urine tested negative by LC-MS/MS.
2 sources Lam et al., Pract Lab Med 2023 de Paula et al., Clin Chem Lab Med 1998
What It Found
- Adding rifampin to drug-free urine reproduced the signal.
Source Daher et al., Clin Chem 2002
What It Found
- In a separate study, two patients tested positive on Syva and Genix after a rifampin dose, while Biosite Triage and GC-MS were negative.
Keep in Mind
- The different results came from testing the same post-dose urine on different products.
Test Studied
- Syva RapidTest, Genix RapidTech and Biosite Triage
All 5 sources Lam et al., Pract Lab Med 2023 de Paula et al., Clin Chem Lab Med 1998 Herrera Trevilla et al., J Anal Toxicol 1995 Daher et al., Clin Chem 2002 Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
Keep in Mind
- The studies do not provide a false-positive rate across current opiates screens.
Imipramine
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists 2.3% cross-reactivity for Imipramine on the Microgenics CEDIA screen.
- At least one other reagent in the same table showed no reaction.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Microgenics CEDIA Opiates (morphine or codeine screen) screen, Krasowski et al. supplement, N
- OPIATES, row 38
Meperidine
Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009
What It Found
- The 2009 comparison lists reactivity at 169,660 ng/mL for Meperidine on the Abbott Architect screen.
- At least one other reagent in the same table showed no reaction.
Keep in Mind
- This laboratory comparison used historical reagents.
- It gives no frequency after routine use.
- The result depends on the reagent, the cutoff and the concentration in the specimen.
Tests Studied
- Abbott Architect Opiates (morphine or codeine screen) screen, Krasowski et al. supplement, N
- OPIATES, row 35
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 0.32% relative response to Meperidine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS opiates urine application on cobas c 501, Table 4
Moxifloxacin
Source Baden et al., JAMA 2001
What It Found
- High spiked concentrations reacted on an older Roche assay.
Keep in Mind
- The older Roche opiate signal required much more drug than the expected peak urine concentration reported in that paper.
Test Studied
- Roche OnLine legacy opiates
Source Colby et al., Clin Biochem 2019
What It Found
- A contemporary comparison found clinically relevant reactivity only on the amphetamine assay, not the opiate screen it tested.
Test Studied
- Abbott MULTIGENT
A Related Drug the Test Picks Up
Hydrocodone
Source Smith et al., J Anal Toxicol 1995
What It Found
- After a controlled dose of hydrocodone, two general opiates tests (TDx and EMIT at a 300 ng/mL cutoff) detected the prescribed opioid in urine.
- Abuscreen also detected hydrocodone.
- Coat-A-Count missed it.
Keep in Mind
- An opiates-class result alone cannot identify the individual opioid.
- The findings depend on the product, cutoff and urine concentration.
Tests Studied
- TDx Opiates, EMIT d.a.u
- Opiate, Abuscreen radioimmunoassay and Coat-A-Count morphine, with urine GC-MS
Source Moody et al., J Anal Toxicol 2006
What It Found
- The authors observed low detection with the OnTrak device in specimens containing hydrocodone or hydromorphone.
Keep in Mind
- The finding concerns sensitivity to a related opioid, not evidence that the patient took morphine.
Test Studied
- OnTrak TesTcup Pro 5 morphine-class screen compared against GC-MS
Source Vanzetti et al., Clin Chem 1983
What It Found
- The authors measured reactivity of Hydrocodone with both historical morphine methods.
- Codeine and ethylmorphine were particularly well recognized.
Keep in Mind
- These antibodies were tested in 1983.
- Their response differs from modern drug-specific opioid screens.
Test Studied
- Experimental morphine hemagglutination-inhibition assay and Roche Abuscreen morphine RIA
Source Smith et al., J Anal Toxicol 2000
What It Found
- The study compared Hydrocodone in fortified urine against morphine.
- At 300 ng/mL, reactivity varied by reagent and generally favored codeine or hydrocodone over oxycodone or oxymorphone.
Keep in Mind
- Relative reactivity is concentration-dependent.
- A measurable signal does not always cross the cutoff.
Test Studied
- Six Roche OnLine, Syva EMIT, CEDIA and AxSYM opiate immunoassay applications
Source Crouch et al., J Anal Toxicol 2002
What It Found
- Expanded confirmation identified hydrocodone or hydromorphone in many opiate-positive specimens.
Keep in Mind
- The study did not isolate a single opioid in every specimen.
Test Studied
- Five on-site urine drug devices in a DUI field study
Source Heltsley et al., J Anal Toxicol 2010
What It Found
- The opiate ELISA detected authentic urines containing only norhydrocodone better than the studied oxycodone assays.
Keep in Mind
- Norhydrocodone is a real metabolite of hydrocodone.
Test Studied
- Opiate ELISA compared with LC-MS/MS
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 22% relative response to Hydrocodone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS opiates urine application on cobas c 501, Table 4
Hydromorphone
Source Smith et al., J Anal Toxicol 1995
What It Found
- After a controlled dose of hydromorphone, two general opiates tests (TDx and EMIT at a 300 ng/mL cutoff) detected the prescribed opioid in urine.
- Abuscreen and Coat-A-Count missed hydromorphone.
Keep in Mind
- An opiates-class result alone cannot identify the individual opioid.
- The findings depend on the product, cutoff and urine concentration.
Tests Studied
- TDx Opiates, EMIT d.a.u
- Opiate, Abuscreen radioimmunoassay and Coat-A-Count morphine, with urine GC-MS
Source Moody et al., J Anal Toxicol 2006
What It Found
- The authors observed low detection with the OnTrak device in specimens containing hydrocodone or hydromorphone.
Keep in Mind
- The finding concerns sensitivity to a related opioid, not evidence that the patient took morphine.
Test Studied
- OnTrak TesTcup Pro 5 morphine-class screen compared against GC-MS
Source Smith et al., J Anal Toxicol 2000
What It Found
- The study compared Hydromorphone in fortified urine against morphine.
- At 300 ng/mL, reactivity varied by reagent and generally favored codeine or hydrocodone over oxycodone or oxymorphone.
Keep in Mind
- Relative reactivity is concentration-dependent.
- A measurable signal does not always cross the cutoff.
Test Studied
- Six Roche OnLine, Syva EMIT, CEDIA and AxSYM opiate immunoassay applications
Source Crouch et al., J Anal Toxicol 2002
What It Found
- Expanded confirmation identified hydrocodone or hydromorphone in many opiate-positive specimens.
Keep in Mind
- The study did not isolate a single opioid in every specimen.
Test Studied
- Five on-site urine drug devices in a DUI field study
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 19% relative response to Hydromorphone.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS opiates urine application on cobas c 501, Table 4
Pholcodine
2 sources Svenneby et al., Forensic Sci Int 1983 Maurer and Fritz, Int J Legal Med 1990
What It Found
- Human studies showed opiate-class screening after therapeutic doses of this morphine-related cough suppressant.
Keep in Mind
- This is a historical or international exposure.
- Detection of this structurally related drug on a broad screen cannot identify morphine or heroin use.
Source Maurer and Fritz, Int J Legal Med 1990
What It Found
- Specific testing identified pholcodine and its metabolites.
Source Meadway et al., Forensic Sci Int 2002
What It Found
- Urine after pholcodine dosing contained measurable free morphine in this study, including after a single 10 mg dose.
Keep in Mind
- The result depends on specimen collection, dilution and analytical method.
- A positive class screen alone does not distinguish these compounds.
Source Wilson and Smith, Ann Clin Biochem 1999
What It Found
- Four samples spiked with 0.5–4 mg/L of pholcodine prompted erroneous reports of morphine by 7–25% of participating laboratories.
Keep in Mind
- The percentage depended on the sample and participating methods.
- Pholcodine is a related opioid.
Test Studied
- UK NEQAS proficiency samples assessed across laboratory methods
3 sources Svenneby et al., Forensic Sci Int 1983 Maurer and Fritz, Int J Legal Med 1990 Meadway et al., Forensic Sci Int 2002
Test Studied
- Opiate RIA, fluorescence polarization and enzyme immunoassays
2 sources Maurer and Fritz, Int J Legal Med 1990 Meadway et al., Forensic Sci Int 2002
Test Studied
- GC-MS with chromatographic separation of pholcodine and morphine
Dihydrocodeine
Source Vanzetti et al., Clin Chem 1983
What It Found
- The authors measured reactivity of Dihydrocodeine with both historical morphine methods.
- Codeine and ethylmorphine were particularly well recognized.
Keep in Mind
- These antibodies were tested in 1983.
- Their response differs from modern drug-specific opioid screens.
Test Studied
- Experimental morphine hemagglutination-inhibition assay and Roche Abuscreen morphine RIA
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 55% relative response to Dihydrocodeine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS opiates urine application on cobas c 501, Table 4
Dihydromorphine
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 38% relative response to Dihydromorphine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS opiates urine application on cobas c 501, Table 4
Ethylmorphine
Source Vanzetti et al., Clin Chem 1983
What It Found
- The authors measured reactivity of Ethylmorphine with both historical morphine methods.
- Codeine and ethylmorphine were particularly well recognized.
Keep in Mind
- These antibodies were tested in 1983.
- Their response differs from modern drug-specific opioid screens.
Test Studied
- Experimental morphine hemagglutination-inhibition assay and Roche Abuscreen morphine RIA
Source Korte et al., J Anal Toxicol 1997
What It Found
- RapiTest MOP recognized Ethylmorphine on the urine morphine screen.
Keep in Mind
- The reported cross-reaction applies to this related opioid and device.
Test Studied
- RapiTest One Step Morphine Test
Nalorphine
Source Vanzetti et al., Clin Chem 1983
What It Found
- Nalorphine was a weak cross-reactant with the historical morphine antibodies studied.
Keep in Mind
- The hemagglutination reagents showed about 0.5% relative molar response.
- Detection after clinical dosing was not studied.
Test Studied
- Historical experimental morphine hemagglutination-inhibition assay and Roche Abuscreen RIA
Thebaine
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 34% relative response to Thebaine.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS opiates urine application on cobas c 501, Table 4
The Test Is Made to Find It
Codeine
3 sources Cone et al., J Anal Toxicol 1993 Storrow et al., Acad Emerg Med 1995 Stolbach et al., J Med Toxicol 2022
What It Found
- Codeine-containing medicines can make an opiate screen positive.
Test Studied
- Morphine-class urine opiate assays
2 sources Cone et al., J Anal Toxicol 1993 Stolbach et al., J Med Toxicol 2022
What It Found
- Codeine and its metabolite morphine can be found by specific testing.
Keep in Mind
- An opiate-class positive cannot identify the medicine or prove illicit use.
Source Vanzetti et al., Clin Chem 1983
What It Found
- The authors measured reactivity of Codeine with both historical morphine methods.
- Codeine and ethylmorphine were particularly well recognized.
Keep in Mind
- These antibodies were tested in 1983.
- Their response differs from modern drug-specific opioid screens.
Test Studied
- Experimental morphine hemagglutination-inhibition assay and Roche Abuscreen morphine RIA
Source Korte et al., J Anal Toxicol 1997
What It Found
- RapiTest MOP recognized Codeine on the urine morphine screen.
Keep in Mind
- The reported cross-reaction applies to this related opioid and device.
Test Studied
- RapiTest One Step Morphine Test
Source Eldefrawi et al., Appl Biochem Biotechnol 2000
What It Found
- Codeine, oxycodone and morphine-6-glucuronide showed more than 50% relative reaction at 1 µg/mL in the experimental system.
Keep in Mind
- The clinical comparison evaluated the overall method, rather than individual drug-only post-dose urines.
Test Studied
- Custom competitive morphine-antibody fluoroimmunoassay
Source Smith et al., J Anal Toxicol 2000
What It Found
- The study compared Codeine in fortified urine against morphine.
- At 300 ng/mL, reactivity varied by reagent and generally favored codeine or hydrocodone over oxycodone or oxymorphone.
Keep in Mind
- Relative reactivity is concentration-dependent.
- A measurable signal does not always cross the cutoff.
Test Studied
- Six Roche OnLine, Syva EMIT, CEDIA and AxSYM opiate immunoassay applications
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 99% for codeine, 61% for codeine-6-glucuronide and 2.3% for norcodeine relative response.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS opiates urine application on cobas c 501, Table 4
Source Podzhilkova et al., Sud Med Ekspert 2020
What It Found
- In a separate prototype strip experiment, parent codeine did not yield a positive morphine result.
Keep in Mind
- The prototype experiment tested parent codeine directly.
Test Studied
- Experimental gold-particle morphine urine strip
2 sources Cone et al., J Anal Toxicol 1993 Podzhilkova et al., Sud Med Ekspert 2020
Keep in Mind
- A person taking codeine may still excrete genuine morphine.
Heroin
Source Cone et al., J Anal Toxicol 1991
What It Found
- Heroin is rapidly metabolized to 6-MAM and then morphine.
Keep in Mind
- A specific urine 6-MAM result has a narrower interpretation.
Source Cone et al., J Anal Toxicol 1993
What It Found
- Its use can produce an expected opiate-class screen.
Keep in Mind
- A positive general opiate screen cannot identify heroin as the source.
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 68% for heroin and 71% for 6-acetylmorphine relative response.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS opiates urine application on cobas c 501, Table 4
2 sources Cone et al., J Anal Toxicol 1993 Cone et al., J Anal Toxicol 1991
Test Studied
- Morphine-class urine opiate immunoassays and GC/MS
Morphine
2 sources Cone et al., J Anal Toxicol 1993 Stolbach et al., J Med Toxicol 2022
What It Found
- Prescribed morphine is a target of routine opiate screening.
Keep in Mind
- A class result does not identify the source of morphine or establish heroin use.
Test Studied
- Morphine-calibrated class assays
Source Cone et al., J Anal Toxicol 1993
What It Found
- Controlled dosing produced positive urine opiate results.
Source Cone et al., J Anal Toxicol 1992
What It Found
- All four assays detected morphine in urine; the Coat-A-Count reagent was more selective for free morphine than the other three.
Keep in Mind
- The reagents were evaluated in 1992.
Test Studied
- Coat-A-Count Morphine, TDx Opiates, Abuscreen Morphine and EMIT d.a.u
Source Eldefrawi et al., Appl Biochem Biotechnol 2000
What It Found
- Codeine, oxycodone and morphine-6-glucuronide showed more than 50% relative reaction at 1 µg/mL in the experimental system.
Keep in Mind
- The clinical comparison evaluated the overall method, rather than individual drug-only post-dose urines.
Test Studied
- Custom competitive morphine-antibody fluoroimmunoassay
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 38% for morphine-3-glucuronide, 47% for morphine-6-glucuronide and 0.19% for normorphine relative response.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS opiates urine application on cobas c 501, Table 4
3 sources Cone et al., J Anal Toxicol 1993 Stolbach et al., J Med Toxicol 2022 Cone et al., J Anal Toxicol 1992
Test Studied
- Opiates
Poppy seeds
Source Smith et al., Forensic Sci Int 2014
What It Found
- Controlled ingestion of raw seeds containing measured morphine and codeine produced genuine urine morphine and codeine.
- Which samples were positive varied with the cutoff.
Keep in Mind
- Food is the source of real opiate molecules here.
- Seed content and preparation differ.
- A definitive heroin-metabolite result requires a separate explanation.
Test Studied
- Roche Opiates II and GC/MS
Suspected, but Not Proven
Tolmetin
Source Joseph et al., J Anal Toxicol 1995
What It Found
- Adding tolmetin to specimens containing opiates lowered the EMIT signal enough for samples to be called negative.
Keep in Mind
- The mechanism and direction matter.
- An instrument error or depressed signal is not evidence of a false-positive screen.
- A separate high-concentration TDx benzodiazepine finding is indexed under benzodiazepines.
Tests Studied
- Older Syva EMIT on Hitachi 704
- Compared with Abbott TDx
Quinine
Source Swift et al., Addict Behav 1989
What It Found
- Tonic water produced detectable urinary quinine in an older study.
- Quinine had been used as an indirect marker of illicit exposure.
Keep in Mind
- That study measured quinine itself.
- It is not direct evidence that quinine makes a modern morphine immunoassay positive.
Tests Studied
- Historical quinine urine marker
- Modern morphine-class opiate assay unverified
Brompheniramine
Source Smith et al., J Anal Toxicol 2000
What It Found
- Adding 1 mg/mL of Brompheniramine to urine already containing 300 ng/mL morphine significantly increased the apparent morphine signal on EMIT and Abbott AxSYM.
Keep in Mind
- This specific experiment demonstrates signal enhancement in morphine-positive urine.
- It did not test whether this drug alone can make morphine-free urine positive.
Test Studied
- EMIT and Abbott AxSYM opiate urine assays, morphine-spiked specimens
Buprenorphine
Source Neukamm et al., Drug Test Anal 2017
What It Found
- The modified assay yielded 0.24% for buprenorphine and 0.1% for norbuprenorphine relative response.
Keep in Mind
- The study spiked a negative calibrator for a modified, low-cutoff urine screening program.
- Relative assay response does not by itself demonstrate a false positive after a prescribed dose or apply to all Roche reagents.
Test Studied
- Modified Roche KIMS opiates urine application on cobas c 501, Table 4
Chlorpheniramine
Source Smith et al., J Anal Toxicol 2000
What It Found
- Adding 1 mg/mL of Chlorpheniramine to urine already containing 300 ng/mL morphine significantly increased the apparent morphine signal on EMIT and Abbott AxSYM.
Keep in Mind
- This specific experiment demonstrates signal enhancement in morphine-positive urine.
- It did not test whether this drug alone can make morphine-free urine positive.
Test Studied
- EMIT and Abbott AxSYM opiate urine assays, morphine-spiked specimens
Ephedrine
Source Smith et al., J Anal Toxicol 2000
What It Found
- Adding 1 mg/mL of Ephedrine to urine already containing 300 ng/mL morphine significantly increased the apparent morphine signal on EMIT.
Keep in Mind
- This specific experiment demonstrates signal enhancement in morphine-positive urine.
- It did not test whether this drug alone can make morphine-free urine positive.
Test Studied
- EMIT opiate urine assays, morphine-spiked specimens
Pseudoephedrine
Source Smith et al., J Anal Toxicol 2000
What It Found
- Adding 1 mg/mL of Pseudoephedrine to urine already containing 300 ng/mL morphine significantly increased the apparent morphine signal on EMIT.
Keep in Mind
- This specific experiment demonstrates signal enhancement in morphine-positive urine.
- It did not test whether this drug alone can make morphine-free urine positive.
Test Studied
- EMIT opiate urine assays, morphine-spiked specimens
Tested: No False Positive Found
Tapentadol
Source Mullins et al., Clin Toxicol (Phila) 2015
What It Found
- Among 11 patients taking therapeutic doses of tapentadol, the researchers found no false-positive results on this general opiates screen.
- Some patients also took other opioid medicines that accounted for positive screens.
Keep in Mind
- A general opiates screen cannot establish whether someone took tapentadol.
- This study examined one assay and a small group.
Test Studied
- Siemens Syva EMIT II urine opiates screen with chromatographic confirmation of positive screens
Acetaminophen
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Acetaminophen at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Clinafloxacin
Source Baden et al., JAMA 2001
What It Found
- Clinafloxacin did not produce a positive by itself on any of the five tested assays.
- There was a small below-cutoff response on CEDIA and EMIT II.
Keep in Mind
- These were bench-comparison findings.
- They do not establish a patient-wide guarantee for other reagents or mixtures.
Test Studied
- Historical Abbott AxSYM, CEDIA, EMIT II, Roche OnLine and Beckman Synchron opiate tests
Meprobamate
Source Lin et al., J Anal Toxicol 2013
What It Found
- The authors observed no interference from Meprobamate at 1,000 ng/mL when it was added to drug-free urine for the cup comparison.
Keep in Mind
- This is a single challenge level.
- It cannot rule out interference at a higher concentration or with a different device.
Test Studied
- NexScreen and DrugCheck Waive RT cups, as applicable to their respective panels
Methadone
Source Vanzetti et al., Clin Chem 1983
What It Found
- The historical hemagglutination antibody series had less than 0.1% relative reactivity to Methadone.
Keep in Mind
- Reactivity depends on the antibody.
- This experiment did not predict every morphine screening method.
Test Studied
- Historical experimental morphine hemagglutination-inhibition assay
Source Eldefrawi et al., Appl Biochem Biotechnol 2000
What It Found
- The authors reported less than 5% response to methadone on this experimental opiates assay.
Keep in Mind
- Low relative reactivity is assay-specific and does not exclude a signal at higher concentrations.
Test Studied
- Custom morphine-antibody fluoroimmunoassay
Nalidixic acid
Source Baden et al., JAMA 2001
What It Found
- Nalidixic acid did not produce a positive by itself on any of the five tested assays.
- The table reports no measurable assay activity.
Source Meatherall and Dai, Ther Drug Monit 1997
What It Found
- An independent EMIT II study was also negative.
Both sources Baden et al., JAMA 2001 Meatherall and Dai, Ther Drug Monit 1997
Keep in Mind
- These were bench-comparison findings.
- They do not establish a patient-wide guarantee for other reagents or mixtures.
Test Studied
- Historical Abbott AxSYM, CEDIA, EMIT II, Roche OnLine and Beckman Synchron opiate tests
Prednisone
Source FDA 510(k) K253567. Healgen Accurate Urine Drug Screen Dip Card and Home Urine Drug Test…, 2025
What It Found
- Prednisone at 100 µg/mL did not cause a positive result in drug-free urine or change the result of urine just below or above this channel’s cutoff.
Keep in Mind
- The manufacturer challenged the assay with parent prednisone.
- This does not test all prednisone metabolites or predict the behavior of other devices.
Tests Studied
- Healgen Accurate multi-drug urine dip card
- The applicable target and cutoff are 300 or 2,000 ng/mL morphine
Sparfloxacin
Source Baden et al., JAMA 2001
What It Found
- Sparfloxacin did not produce a positive by itself on any of the five tested assays.
- There was a small below-cutoff response on CEDIA, EMIT II and Roche OnLine.
Keep in Mind
- These were bench-comparison findings.
- They do not establish a patient-wide guarantee for other reagents or mixtures.
Test Studied
- Historical Abbott AxSYM, CEDIA, EMIT II, Roche OnLine and Beckman Synchron opiate tests
Trovafloxacin
Source Baden et al., JAMA 2001
What It Found
- Trovafloxacin did not produce a positive by itself on any of the five tested assays.
- The table reports no measurable assay activity.
Keep in Mind
- These were bench-comparison findings.
- They do not establish a patient-wide guarantee for other reagents or mixtures.
Test Studied
- Historical Abbott AxSYM, CEDIA, EMIT II, Roche OnLine and Beckman Synchron opiate tests